Scientists with Deakin’s School of Medicine have found that, when coupled with the milk protein lactoferrin, the chemotherapy drug Doxorubicin (Dox) can be delivered directly into the nucleus of prostate cancer cells and will kill them cells as well as drug resistant cancer stem cells, without any side-effects. Read the article here.
Prostate Cancer Treatment Breakthrough Read More »
Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to new research from Weill Cornell Medicine and NewYork-Presbyterian. Read the article here.
Early assessment, drug switch improves cancer treatment Read More »
Not all men with prostate cancer benefit from adjuvant chemotherapy after radical prostatectomy; however, African American men and men with a higher tumor stage may, according to a new U.S. Department of Veterans Affairs (VA) study. Read the article.
Two papers from University College London show that having early chemotherapy improves survival for men with prostate cancer. Read the article.
Early chemotherapy improves survival for men with prostate cancer Read More »
Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months longer than men who received only hormone therapy (58 months versus 44 months), researchers said. Read the article.
Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study Read More »
A medical researcher with the University of Alberta and his team just published their findings about their work on developing ‘homing beacon drugs’ that kill only cancer cells, not healthy ones, thanks to nano-technology. Read More.
‘Homing Beacon Drugs’ to Target Cancer Cells Read More »
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a “molecular grenade,” and sparing healthy blood vessels and tissues. Read More.
Drug from Mediterranean weed kills tumor cells in mice Read More »